Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 18, Issue 11, pp. 3100-3111
PubMed
Published By
Print ISSN
Online ISSN
History
- Received July 20, 2011
- Revision received March 20, 2012
- Accepted March 29, 2012
- Published first April 12, 2012.
Article Versions
- Previous version (April 12, 2012 - 11:45).
- Previous version (May 9, 2012 - 11:34).
- You are viewing the most recent version of this article.
Copyright & Usage
©2012 American Association for Cancer Research.
Author Information
- Alan McIntyre1,
- Shalini Patiar1,
- Simon Wigfield1,
- Ji-liang Li1,
- Ioanna Ledaki1,
- Helen Turley1,3,
- Russell Leek1,3,
- Cameron Snell1,3,
- Kevin Gatter3,
- William S. Sly4,
- Richard D. Vaughan-Jones2,
- Pawel Swietach2, and
- Adrian L. Harris1
- Authors' Affiliations: 1Molecular Oncology Laboratories, Department of Medical Oncology, Weatherall Institute of Molecular Medicine, 2Department of Physiology, Anatomy and Genetics, Burdon Sanderson Cardiac Science Centre, 3Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom; and 4St. Louis University School of Medicine, St. Louis, Missouri
- Corresponding Author:
Adrian L. Harris, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, United Kingdom. Phone: 44-01865-222457; Fax: 44-01865-222431; E-mail: aharris.lab{at}oncology.ox.ac.uk
A. McIntyre and S. Patiar contributed equally to this work.
June 2012
Volume 18, Issue 11
Volume 18, Issue 11
Carbonic Anhydrase IX Promotes Tumor Growth and Necrosis In Vivo and Inhibition Enhances Anti-VEGF Therapy
Jump to section
Advertisement